BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2133273)

  • 1. Cyclic oxygen analogues of alkyl-lysophospholipids. Synthesis and neoplastic cell growth inhibitory properties.
    Houlihan WJ; Lee ML; Munder PG; Winslow CM; Cheon SH; D'Aries FJ; DeLillo AK; Jaeggi CS; Mason RB; Parrino VA
    J Lipid Mediat; 1990; 2(5):295-307. PubMed ID: 2133273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of a piperidine phospholipid.
    Houlihan WJ; Lee ML; Munder PG; Handley DA; Nemecek GA; Jaeggi CS; Winslow CW
    Arzneimittelforschung; 1994 Dec; 44(12):1384-8. PubMed ID: 7848363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric flow cytometry of the modulation of tumor cell membrane permeability by developmental antitumor ether lipid SRI 62-834 in EMT6 mouse mammary tumor and HL-60 human promyelocytic leukemia cells.
    Dive C; Watson JV; Workman P
    Cancer Res; 1991 Feb; 51(3):799-806. PubMed ID: 1988120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of correlation between cytotoxicity of agonists and antagonists of platelet activating factor [paf-acether] in neoplastic cells and modulation of [3H]-paf-acether binding to platelets from humans in vitro.
    Berdel WE; Korth R; Reichert A; Houlihan WJ; Bicker U; Nomura H; Vogler WR; Benveniste J; Rastetter J
    Anticancer Res; 1987; 7(6):1181-7. PubMed ID: 3442414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analogues.
    Seewald MJ; Olsen RA; Sehgal I; Melder DC; Modest EJ; Powis G
    Cancer Res; 1990 Aug; 50(15):4458-63. PubMed ID: 2369723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of novel steroid-modified ether phospholipids.
    Karantonis HC; Pitsinos EN; Antonopoulou S; Couladouros EA; Demopoulos CA
    Chem Phys Lipids; 2005 Dec; 138(1-2):12-9. PubMed ID: 16202400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L).
    Mollinedo F; Fernández-Luna JL; Gajate C; Martín-Martín B; Benito A; Martínez-Dalmau R; Modolell M
    Cancer Res; 1997 Apr; 57(7):1320-8. PubMed ID: 9102220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic effects of hexadecylphosphocholine in neoplastic cell lines including drug-resistant sublines in vitro.
    Danhauser-Riedl S; Himmelmann A; Steinhauser G; Busch R; Vogler WR; Rastetter J; Berdel WE
    J Lipid Mediat; 1990; 2(5):271-80. PubMed ID: 2133272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some antagonists of platelet activating factor are cytotoxic for human malignant cell lines.
    Danhauser-Riedl S; Felix SB; Houlihan WJ; Zafferani M; Steinhauser G; Oberberg D; Kalvelage H; Busch R; Rastetter J; Berdel WE
    Cancer Res; 1991 Jan; 51(1):43-8. PubMed ID: 1988103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of SRI 62-834, a cyclic ether analog of ET-18-OCH3.
    Houlihan WJ; Lee ML; Munder PG; Nemecek GM; Handley DA; Winslow CM; Happy J; Jaeggi C
    Lipids; 1987 Nov; 22(11):884-90. PubMed ID: 2832680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).
    Marino-Albernas JR; Bittman R; Peters A; Mayhew E
    J Med Chem; 1996 Aug; 39(17):3241-7. PubMed ID: 8765506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of the R- and S-enantiomers of RS-2-[[hydroxy[[2-[ (octadecyloxy)methyl]tetrahydrofuran-2-yl]methoxy]-phosphinyl]oxy]-N, N,N,-trimethylethylaminium hydroxide inner salt.
    Houlihan WJ; Prasad K; Underwood R; Repic O; Munder PG
    J Med Chem; 1996 Jan; 39(2):605-8. PubMed ID: 8558533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
    Chabot MC; Wykle RL; Modest EJ; Daniel LW
    Cancer Res; 1989 Aug; 49(16):4441-5. PubMed ID: 2743333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokinetic and morphologic differences in ovarian cancer cells treated with ET-18-OCH3 and the DNA-interacting agent, etoposide.
    Fujiwara K; Koike H; Ohishi Y; Shirafuji H; Kohno I; Modest EJ; Kataoka S
    Anticancer Res; 1997; 17(3C):2159-67. PubMed ID: 9216681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between cellular ether glycerophospholipid content and sensitivity of cancer cells to 1-O-octadecyl-2-O-methyl-glycerophosphocholine.
    Zhou X; Lu X; Arthur G
    Anticancer Res; 1992; 12(5):1659-62. PubMed ID: 1444233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of leukemia cell lines to cytotoxic alkyl-lysophospholipids in relation to O-alkyl cleavage enzyme activities.
    Unger C; Eibl H; Kim DJ; Fleer EA; Kötting J; Bartsch HH; Nagel GA; Pfizenmaier K
    J Natl Cancer Inst; 1987 Feb; 78(2):219-22. PubMed ID: 3468284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships in platelet-activating factor (PAF). 5. Synthesis and in vitro antagonistic activities of ketophosphonates.
    Furno-de Winter A; Broquet C; Haelters JP; Massicot F; Sturtz G; Godfroid JJ
    J Lipid Mediat; 1991; 3(3):289-300. PubMed ID: 1773030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of epidermal growth factor binding in human breast cancer cell lines by an alkyl-lysophospholipid.
    Kosano H; Takatani O
    Cancer Res; 1988 Nov; 48(21):6033-6. PubMed ID: 3262419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased sensitivity to 1-O-octadecyl-2-O-methyl-glycerophosphocholine in MCF-7 cells adapted for serum-free growth correlates with constitutive association of Raf-1 with cellular membranes.
    Samadder P; Arthur G
    Cancer Res; 1999 Oct; 59(19):4808-15. PubMed ID: 10519389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel nontoxic alkyl-phospholipid with selective antitumor activity, plasmanyl-(N-acyl)-ethanolamine (PNAE), isolated from degenerating chick embryonal tissues and from an anticancer biopreparation cACPL.
    Kára J; Borovicka M; Liebl V; Smolíková J; Ubik K
    Neoplasma; 1986; 33(2):187-205. PubMed ID: 3713923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.